These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 24704988)
1. A new tool for distinguishing muscle invasive and non-muscle invasive bladder cancer: the initial application of flexible ultrasound bronchoscope in bladder tumor staging. Xu C; Zhang Z; Wang H; Song Q; Wei R; Yu Y; Li J; Sun Y PLoS One; 2014; 9(4):e92385. PubMed ID: 24704988 [TBL] [Abstract][Full Text] [Related]
2. Management of high-risk non-muscle invasive bladder cancer. Brausi M; Olaru V Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212 [TBL] [Abstract][Full Text] [Related]
3. [A second transurethral resection could be not necessary in all high grade non-muscle-invasive bladder tumors]. Gaya JM; Palou J; Cosentino M; Patiño D; Rodríguez-Faba O; Villavicencio H Actas Urol Esp; 2012 Oct; 36(9):539-44. PubMed ID: 22710093 [TBL] [Abstract][Full Text] [Related]
4. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience. Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376 [TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of surgical margins in non-muscle invasive bladder cancer following primary transurethral resection. Özsoy Ç; Demir Y; Yılmaz K; Ölçücü MT; Kılıç Ş; Ateş M Fr J Urol; 2024 Sep; 34(9):102705. PubMed ID: 39059766 [TBL] [Abstract][Full Text] [Related]
6. Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer. Colombo R; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Lucianò R; Conti G; Magnani T; Capogrosso P; Conti A; Pasini L; Burgio G; Guazzoni G; Patriarca C Eur Urol Focus; 2018 Jan; 4(1):87-93. PubMed ID: 28753746 [TBL] [Abstract][Full Text] [Related]
7. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M; Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737 [TBL] [Abstract][Full Text] [Related]
8. Value of repeat radical transurethral resection for selected patients with muscle-invasive bladder cancer. Li Z; Li Y; Lu Q; Chen J ANZ J Surg; 2018 Oct; 88(10):1033-1036. PubMed ID: 29974604 [TBL] [Abstract][Full Text] [Related]
9. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder. Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101 [TBL] [Abstract][Full Text] [Related]
10. The value of a second transurethral resection for T1 bladder cancer. Schwaibold HE; Sivalingam S; May F; Hartung R BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814 [TBL] [Abstract][Full Text] [Related]
11. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer. Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637 [TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study. Kamiya N; Suzuki H; Suyama T; Kobayashi M; Fukasawa S; Sekita N; Mikami K; Nihei N; Naya Y; Ichikawa T Int J Clin Oncol; 2017 Apr; 22(2):353-358. PubMed ID: 27744487 [TBL] [Abstract][Full Text] [Related]
15. Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens. Hwang MJ; Kamat AM; Dinney CP; Czerniak B; Guo CC Am J Clin Pathol; 2020 Jul; 154(2):208-214. PubMed ID: 32253420 [TBL] [Abstract][Full Text] [Related]
16. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application. Makboul M; Farghaly S; Abdelkawi IF Br J Radiol; 2019 Dec; 92(1104):20190401. PubMed ID: 31573328 [TBL] [Abstract][Full Text] [Related]
17. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances. Paner GP; Montironi R; Amin MB Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951 [TBL] [Abstract][Full Text] [Related]
18. Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer. Xu S; Yao Q; Liu G; Jin D; Chen H; Xu J; Li Z; Wu G Eur Radiol; 2020 Mar; 30(3):1804-1812. PubMed ID: 31773297 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection. Chang WC; Chang YH; Pan CC Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706 [TBL] [Abstract][Full Text] [Related]
20. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. Paik ML; Scolieri MJ; Brown SL; Spirnak JP; Resnick MI J Urol; 2000 Jun; 163(6):1693-6. PubMed ID: 10799162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]